Literature DB >> 15644152

[Combined use of factor analysis and cluster analysis in classification of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis].

Qin Zhang1, Wen-Tong Zhang, Jian-Jun Wei, Xian-Bo Wang, Ping Liu.   

Abstract

OBJECTIVE: To explore the significance of the combination of factor analysis and systematic cluster analysis in classification of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis, and to provide a scientific basis for the criterion of the classification.
METHODS: We designed a clinical questionnaire according to the clinical characteristics and the demands of traditional Chinese medical information collection for patients with posthepatitic cirrhosis. By means of clinical epidemiological research, with the four diagnosis methods for clinical information collection of traditional Chinese medicine, symptoms, physical signs, tongue conditions and pulse conditions in 310 patients with posthepatitic cirrhosis were collected, and the characteristics of traditional Chinese medical syndromes in these patients were explored with statistical methods, such as factor analysis, varimax and systematic cluster analysis.
RESULTS: Analyzed by factor analysis and systematic cluster analysis with SPSS 11.0, the traditional Chinese medical syndromes in 287 of the 310 cases (92.58%) of posthepatitic cirrhosis could be classified. The syndromes could be divided into 7 categories, which were internal accumulation of damp-heat (55 cases), insufficiency of the spleen with overabundance of dampness (74 cases), accumulation of blood stasis plus deficiency of liver-yin and kidney-yin (73 cases), accumulation of blood stasis plus deficiency of both blood and qi (40 cases), deficiency of both blood and qi (16 cases), deficiency of yin and blood heat (6 cases) and stagnation of the liver-qi and deficiency of the spleen (23 cases). The traditional Chinese medical syndromes in the other 23 cases could not be classified.
CONCLUSIONS: The clinical information collected with the four diagnostic methods of traditional Chinese medicine can be classified into different categories with the factor analysis and systematic cluster analysis. The factor analysis and systematic cluster analysis can reveal the characteristics and regularity of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis in a way, and have value in researching the syndromes of traditional Chinese medicine.

Entities:  

Mesh:

Year:  2005        PMID: 15644152     DOI: 10.3736/jcim20050105

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  5 in total

1.  Syndrome classification based on manifold ranking for viral hepatitis.

Authors:  Yu-feng Zhao; Li-yun He; Bao-yan Liu; Jun Li; Feng-yi Li; Rui-li Huo; Xiang-hong Jing
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

2.  Topic model for Chinese medicine diagnosis and prescription regularities analysis: case on diabetes.

Authors:  Xiao-Ping Zhang; Xue-Zhong Zhou; Hou-Kuan Huang; Qi Feng; Shi-Bo Chen; Bao-Yan Liu
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

3.  Inquiry diagnosis of coronary heart disease in Chinese medicine based on symptom-syndrome interactions.

Authors:  Guo-Zheng Li; Sheng Sun; Mingyu You; Ya-Lei Wang; Guo-Ping Liu
Journal:  Chin Med       Date:  2012-04-05       Impact factor: 5.455

4.  Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.

Authors:  Xiaoning Wang; Guoxiang Xie; Xiaoyan Wang; Mingmei Zhou; Huan Yu; Yan Lin; Guangli Du; Guoan Luo; Ping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-18       Impact factor: 2.629

5.  A Novel Framework for Understanding the Pattern Identification of Traditional Asian Medicine From the Machine Learning Perspective.

Authors:  Hyojin Bae; Sanghun Lee; Choong-Yeol Lee; Chang-Eop Kim
Journal:  Front Med (Lausanne)       Date:  2022-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.